Returning U.S. manufacturing employment to a level that remotely resembles its historical peak will be an uphill battle,” the ...

Mature overall survival results of the INAVO120 trial were presented in a press conference for the American Society of ...

Merck & Co. is undervalued with strong oncology growth, key R&D investments, and shareholder returns. Click here to read an ...

The stock's fall snapped a four-day winning streak.

Those two descriptions definitely apply to the healthcare sector. People need healthcare products and services regardless of ...

Merck offers a 4.2% dividend yield but faces uncertainty with KEYTRUDA's LOE. Click here to find out why MRK stock is a Hold.

Today, Benzinga 's options scanner spotted 33 uncommon options trades for Merck & Co. This isn't normal. The overall ...

The State of Kansas announced an $895 million capital expansion project at the Merck Animal Health manufacturing facility in ...

We came across a bullish thesis on Merck & Co., Inc. (MRK) on Value Investing Subreddit Page by CompanyCharts. In this ...

After meeting the mark alongside Keytruda in PD-L1-positive breast cancer earlier this year, Gilead Sciences' antibody-drug ...

ZoomRx polled 50 experienced oncologists and hemato-oncologists about 20 cancer drugmakers, asking the doctors to rank the ...